No description available.

No description available.

Ovaries maintain and produce functional female gametes, oocytes, for fertilisation. Oocytes develop inside cellular assemblies, the ovarian follicles, before birth and can reside there for up to 50 years in the human. Despite recent inroads, the precise mechanisms of initial follicle recruitment and growth remain unclear. Although the pituitary gonadotrophins play a role in this developmental process, locally produced factors have been implicated strongly in initiation of follicle growth. It is known that fibroblast growth factor 2 (FGF2) is a powerful mitogen for follicular granulosa cells in culture and initial studies undertaken in this project were successful in detecting FGF2 gene expression in ovarian biopsies from fertile healthy women. To further elucidate which cells were expressing FGF2, laser microdissection was employed to isolate differentially staged follicle populations. Real-time RT-PCR was used to quantify mRNA in relation to follicle development. Decreasing levels of FGF2 expression were detected as follicles developed. Non-radioactive in situ hybridisation confirmed FGF2 mRNA localisation in granulosa cells of preantral follicles. FGF2 protein localisation was assessed with immunohistochemistry; two primary antibodies raised against different fragments of human FGF2 were used. Both antibodies detected FGF2 in the oocyte cytoplasm of putative non-growing follicles, whereas only one of the antibodies showed additional reactivity to the basement membrane region of these same follicles. These results suggest different isoforms of FGF2 may localise specifically to different cellular sites. Follicle stimulating hormone receptor (FSHR) gene expression was also investigated in follicles using laser microdissection, real-time RT-PCR and in situ hybridisation. FSHR mRNA was detected in all follicle populations, including the smallest putative non-growing follicles. Disparity to other published works was attributed to the position of primer annealing, and thus the ability to detect alternatively spliced transcripts. In conclusion, the work presented here provides evidence that FGF2 and FSHR are present in small follicles and that their actions may be stimulatory or inhibitory to initial follicle recruitment.

A German pathologist first described defects in the elastic tissues of human arteries over one hundred years ago. Much evidence now supports the involvement of these elastic tissue defects (ETDs) in the initiation and progression of atherosclerosis, although this association is not well accepted. Recent research has determined that the migration of medial smooth muscle cells into the intima (and therefore the start of the atherosclerotic process) is initiated in an attempt to repair these defects and in addition, that there is a correlation between the extent of intimal thickening and the degree of elastic tissue disruption. The Brown Norway (BN) strain appears to have an increased predilection, having a significantly greater incidence of ETDs within the caudal and renal arteries and the abdominal aorta compared with other rat strains. These defects appear morphologically identical to those observed in the arteries of young humans. The purpose of this study was to determine the magnitude of the genetic and environmental components in the formation of these ETDs in the aorta. Previous studies have demonstrated that the spontaneous formation of elastic tissue defects in the abdominal aorta of the Brown Noway rat is a genetically inherited phenotype, passed from parent to offspring in an autosomal dominant manner. Following crossbreeding of the BN rat with four other strains (two hypertensive and two normotensive) it was determined that, although the inheritance mode of the ETD phenotype followed an autosomal dominant pattern, the expression or penetrance of this phenotype was reduced in F₁ all crossbred groups. Moreover, the early postnatal growth profile of the F₁ pups appeared to be differentially associated with defect formation. To further examine the relationship between aortic ETDs and birthweight, a well-studied model of in utero growth restriction was investigated in the BN rat. On day 18 of a 23-day gestation the uterine arteries were ligated, which resulted in offspring that were 14% smaller than un-operated control pups. This short-term insult resulted in significantly increased numbers of ETDs in growth-restricted animals at 8 weeks of age, an effect that was also observed in 16-week old males. The effect of in utero growth restriction on ETDs in the guinea pig and ApoE knockout mouse was also examined, to determine if ETDs (and subsequent early atherosclerotic events) may be influenced by the exposure to a growth-restricting event in utero. Despite this work leading to the novel characterisation of ETDs in the guinea pig aorta, the growth restricting surgery resulted in poor maternal and pup outcomes, which limited the conclusions that could be drawn from these studies. Furthermore, microarray techniques were employed to examine changes in aortic gene expression following growth restriction, by comparing amplified mRNA extracts from 8-week old growth restricted BN pup aortas with extracts from a group of average birthweight, un-operated BN pups. In combination, these studies propose both genetic inheritance and the in utero environment regulate elastic tissue defect phenotype, which in turn potentially affects the initiation and progression of early atherosclerosis.

Thesis (M.S.)--Oregon State University, 2007. / Printout. Includes bibliographical references (leaves 56-62). Also available on the World Wide Web.

Thesis (Ph. D.)--Ohio State University, 2006. / Title from first page of PDF file. Includes bibliographical references (p. 109-124).

Thesis (Ph. D.)--Ohio State University, 2006. / Full text release at OhioLINK's ETD Center delayed at author's request

Increased circulating levels of glucocorticoids observed in many catabolic conditions play a major role in the induction of muscle atrophy. Indeed, inhibition of glucocorticoid action by glucocorticoid receptor antagonist attenuates and, in some cases, abolishes muscle atrophy. Circulating and tissue levels of IGF-I, a growth factor that stimulates the development of muscle mass, are frequently reduced in response to glucocorticoids. This decline could therefore trigger muscle atrophy in catabolic conditions. Indeed, systemic administration of IGF-I prevents glucocorticoid-induced muscle atrophy. However, use of systemic IGF-I administration is limited by its hypoglycemic and cardiac hypertrophic actions. Moreover, local IGF-I seems to play a more important role in the regulation of muscle mass than systemic IGF-I. Therefore, to limit loss of muscle mass observed in catabolic states, IGF-I administration must mimic as close as possible the autocrine production of IGF-I. The aim of this thesis was to investigate whether the restoration of IGF-I muscle content could reverse muscle atrophy induced by glucocorticoids. In this work we have tested the hypothesis that the local decrease in muscle IGF-I content might be responsible for the muscular atrophy induced by glucocorticoids. In our work, we have demonstrated that localized overexpression of IGF-I by gene electrotransfer prevents muscle atrophy in glucocorticoid-treated rats. High rate of fiber transfection and long term gene expression were obtained by combining multiple injection sites of DNA with electroporation. Human IGF-I gene electrotransfer using this optimised protocol resulted in increased muscle IGF-I mRNA and protein levels together with prevention of loss of skeletal muscle mass. Furthermore, alterations in the Akt/GSK-3â/â-catenin signaling pathway caused by glucocorticoids were prevented by local IGF-I gene overexpression. Finally, muscle overexpression of caAkt, dnGSK-3b and ÄNb-catenin was sufficient to mimic the anti-atrophic effect of IGF-I supporting the role of this signalling pathway in muscle atrophy caused by glucocorticoids. Taken together, our results show, for the first time in vivo, the role of the IGF-I/Akt/GSK-3b/b-catenin pathway in the skeletal muscle atrophy caused by glucocorticoids. In conclusion, our work highlights the crucial role of decreased muscle IGF-I in glucocorticoid-induced muscle atrophy. Indeed, the data presented in this thesis support the fact that the atrophic action of glucocorticoids is in part due to the downregulation of IGF-I, leading to the inhibition of its signalling pathways while restoration of muscle IGF-I levels is able to counteract totally muscle atrophy.

The meniscus is a soft, fibrocartilaginous tissue critical for the maintenance of normal knee biomechanics, providing shock absorbance and overall joint lubrication and stability. The adult tissue is highly avascular with a poor autonomous repair capacity in response to injury. Despite the estimated 850,000 arthroscopic surgeries performed per year to repair torn menisci and the increasing evidence showing a high incidence of meniscal degeneration during very early stages of osteoarthritis, little is currently known of the responses of meniscal fibrochondrocytes to physiological stimuli. Therefore, this work explored the responses of meniscal fibrochondrocytes to exogenous biomechanical and biochemical stimuli in an effort to better understand the sensitivity of these cells in their native tissue matrix as well as in a 3-D scaffold environment. Using the immature bovine model, the changes in biosynthesis of fibrochondrocytes in tissue explants and in an agarose scaffold due to unconfined oscillatory compression were explored. This biomechanical stimulus, previously identified to stimulate matrix production of chondrocytes of articular cartilage, stimulated total protein synthesis in both culture environments. In contrast, the synthesis of proteoglycans, matrix components important in mechanical stiffness and hydration of the tissue, was not affected by these compression protocols. However, the use of a biochemical stimulus in the form of anabolic cytokines significantly enhanced both protein and proteoglycan synthesis as a function of culture environment as well as type of cytokine used. The superposition of oscillatory compression in addition to the use of these potent biochemical stimulators, insulin-like growth factor-I or transforming growth factor-beta 1, did not further enhance matrix synthesis of fibrochondrocytes in agarose culture, suggesting an insensitivity of the fibrochondrocytes to biomechanical stimuli during early stages of matrix maturation within the agarose scaffold. As a combination of biomechanical and biochemical stimuli are responsible for directing the development, maintenance, and repair of the tissue, these findings aid in understanding fibrocartilage maintenance through studying responses in a tissue explant model. Additionally, studying agarose scaffolds aid in the understanding fibrocartilage development and deposition of a de novo matrix.

The adult Drosophila central nervous system is produced by two phases of neurogenesis: the first phase occurs during embryonic development where the larval brain is formed and the second occurs during larval development to form the adult brain. Neurogenesis in both phases is caused by the activation of neural stem cell division and subsequent progenitor cell division and terminal differentiation. Proper activation of neural stem cell division in the larval brain is essential for proper patterning and functionality of the adult central nervous system. Initiation of neural stem cell proliferation requires signaling from the Fibroblast Growth Factor (FGF) homolog Branchless (Bnl) and by the Hedgehog (Hh) growth factor. I have focused on the interactions between both of these signaling pathways with respect to post-embryonic neural stem cell proliferation using the Drosophila larval brain. Using proliferation assays and quantitative real-time PCR, I have shown that Bnl and Hh signaling is inter-dependent in the 1st instar larval brain and activates neural stem cell proliferation. I have also shown that overexpression of bnl can rescue signaling and neuroblast proliferation in a hh mutant. However, overexpression of hh does not rescue signaling or neuroblast proliferation in a bnl mutant, suggesting that Bnl is the signaling output of the Bnl-Hh feedback loop and that all central brain and optic lobe neural stem cells require Bnl signaling to initiated proliferation.